高级检索
当前位置: 首页 > 详情页

Metastatic Lung Adenocarcinoma Received Combined 177 Lu-FAP-2286 Radiation Therapy and Targeted Therapy

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of NuclearMedicine, The Affiliated Hospital of Southwest Medical University/Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province and Institute of NuclearMedicine, SouthwestMedical University, Luzhou, Sichuan, China
出处:
ISSN:

关键词: 177Lu-FAP-2286 radiation therapy targeted therapy combined therapy lung adenocarcinoma

摘要:
A 56-year-old man with metastatic lung adenocarcinoma received combined 177 Lu-FAP-2286 radiation therapy and targeted therapy. After 1 treatment cycle, improvement of symptoms and radiological remission was observed. Moreover, the patient did not report any adverse effects.Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 核医学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 核医学
第一作者:
第一作者机构: [1]Department of NuclearMedicine, The Affiliated Hospital of Southwest Medical University/Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province and Institute of NuclearMedicine, SouthwestMedical University, Luzhou, Sichuan, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of NuclearMedicine, The Affiliated Hospital of Southwest Medical University/Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province and Institute of NuclearMedicine, SouthwestMedical University, Luzhou, Sichuan, China [*1]Department of Nuclear Medicine, The Affiliated Hospital of SouthwestMedical University, No. 25 TaiPing St, Jiangyang District, Luzhou, Sichuan, 646000, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号